The BET degrader BETd-246 demonstrated significant anti-tumor efficacy in T-cell acute lymphoblastic leukemia by inhibiting TRAT1

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 98c754338d7dfa26-ATL IP: 47.97.18.252 UTC time: 2025-10-10T16:00:08+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4

Comments (0)

No login
gif